Leveraging AI and Research Platforms to Accelerate Next-Generation Biological Modalities
As biologic modalities such as in vivo CAR therapies and antibody-drug conjugates (ADCs) rapidly advance, the need for efficient and scalable development solutions continues to grow. Join our webinar to..
